Topic
SpaceX Research
Current institutional research highlights a market environment that prioritizes private equity and large-scale technological infrastructure, both of which are central to the SpaceX narrative. While Goldman Sachs reports aggressive selling within the Industrials sector, there is a persistent institutional appetite for private markets as diversifiers that offer higher returns and lower volatility than traditional public indices. This focus on private assets is increasingly relevant as BlackRock emphasizes a 'speed and scarcity' theme, particularly regarding the projected $1 trillion annual AI infrastructure buildout. Despite potential headwinds from hawkish Federal Reserve policies and high institutional leverage reaching five-year peaks, there remains a tactical preference for U.S. equities and technology beneficiaries. Additionally, the development of liquid private equity investment vehicles is bridging the gap for retail access to historically illiquid segments of the market. Consequently, the research suggests that while the broader industrial sector faces selling pressure, capital continues to flow toward high-growth, private-market leaders that define the next generation of technological expansion.
4165 reports available
All reports
Page 160 of 168
How Can I Invest in Transformational Innovation
UBS · May 11, 2026
Monday Movers Dissected
Citigroup Inc. · May 11, 2026
Forced To Chase
The Market Ear · May 11, 2026
Guide to US CPI Risks
Citi · May 11, 2026
Korea and Taiwan: How to Manage AI-Driven Super Surplus
Goldman Sachs · May 11, 2026
Market Focus Shift from Buybacks to Capex
The Market Ear · May 11, 2026
Ever Higher
Ratios (Natixis / Groupe BPCE) · May 11, 2026
China's Industrial Policy: Lessons and Realities
Natixis Corporate and Investment Banking · May 11, 2026
Sony Group CEO and CFO Meeting
Goldman Sachs Japan Co., Ltd. · May 11, 2026
Middle East Daily
MUFG · May 11, 2026
Introduce Bepirovirsen From GSK to Enrich Hepatitis Portfolio
Goldman Sachs · May 11, 2026
Australian Morning Focus
ANZ · May 11, 2026
Evaluating Execution Risk for Avexitide Phase 3 Readout in Post-Bariatric Hypoglycemia
Goldman Sachs · May 11, 2026
1Q New Guidance Above Expectations: AI Capex Benefits Are Broadening
Goldman Sachs · May 11, 2026
Nippon Yusen Earnings Review
Goldman Sachs · May 11, 2026
Shyam Metalics and Energy Q4FY26 Results Review
Goldman Sachs · May 11, 2026
Good Morning Mail
Goldman Sachs · May 11, 2026
Americas Small Cap Research Summary
Barclays · May 11, 2026
Macro Volatility Digest
Cboe · May 11, 2026
Inside Commodities
LSEG Data & Analytics · May 11, 2026
Iran Resolution Market Impact
UBS · May 11, 2026
US Market Intelligence Morning Briefing
J.P. Morgan · May 11, 2026
Goldilocks Jobs Data in April
Western Asset · May 11, 2026
Markets Today
Bank of New Zealand · May 11, 2026